Explore Diverse Views.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
Artificial Intelligence
Donald Trump
Friedrich Merz
European Central Bank
Social Media
Nintendo
European Union
NATO
Senate
Natural Disasters
Travel
Published • loading... • Updated

BioNTech Presents Impressive Early Data for PD-L1xVEGF in Mesothelioma

Summary by endpoints.news
CHICAGO — BioNTech reported promising Phase 2 data in a rare and aggressive lung and abdomen cancer from its experimental PD-L1xVEGF compound, a drug that’s now at the center of a massive $1.5 billion-plus deal ...

2 Articles

All
Left
1
Center
Right
www.t-online.dewww.t-online.de
Lean Left

Biontech Announces New Drug for Cancer

A new cancer drug is to be used against several tumours. It is developed by the German company Biontech and a partner.

Read Full Article
endpoints.newsendpoints.news

BioNTech presents impressive early data for PD-L1xVEGF in mesothelioma

CHICAGO — BioNTech reported promising Phase 2 data in a rare and aggressive lung and abdomen cancer from its experimental PD-L1xVEGF compound, a drug that’s now at the center of a massive $1.5 billion-plus deal ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

www.t-online.de broke the news in on Tuesday, June 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer

Cancer

Mainz

Mainz

Chicago, IL

Chicago, IL

News
For You
SearchBlindspotLocal